NewsRx

Search our medical news database

Adams Respiratory Therapeutics, Inc.

Adams Respiratory Therapeutics Ranked in Top 10 of Deloitte's Technology Fast 50 Program for New Jersey

Published in Healthcare Mergers, Acquisitions and Ventures Week, September 8th, 2007

Adams Respiratory Therapeutics, Inc. (NASDAQ:ARXT) announced that it has been named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Rankings are based on companies' percentage revenue growth over the five year period from 2002 to 2006. Deloitte & Touche USA LLP, is one of the nation's leading professional services organizations.

Adams Respiratory Therapeutics' CEO Michael J. Valentino said, "I am extremely pleased that Adams was ranked seventh overall, out of the companies honored in Deloitte's Technology Fast 50 program. We...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook